HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. | Vanderbilt Translational and Clinical Cardiovascular Research Center (VTRACC)

Armah KA, McGinnis K, Baker J, Gibert C, Butt AA, Bryant KJ, Goetz M, Tracy R, Oursler KK, Rimland D, Crothers K, Rodriguez-Barradas M, Crystal S, Gordon A, Kraemer K, Brown S, Gerschenson M, Leaf DA, Deeks SG, Rinaldo C, Kuller LH, Justice A, Freiberg M. HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012 Jul;55(55). 126-36. PMID: 22534147 [PubMed] PMCID: PMC3493182

Abstract

Biomarkers of inflammation, altered coagulation, and monocyte activation are associated with mortality and cardiovascular disease (CVD) in the general population and among human immunodeficiency virus (HIV)-infected people. We compared biomarkers for inflammation, altered coagulation, and monocyte activation between HIV-infected and uninfected people in the Veterans Aging Cohort Study (VACS).